Matsutani T - Search Results

1

Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction.

Wang H, Lu H, Zhang XM, Goto KI, Kobayashi E, Yoshida Y, Adachi A, Matsutani T, Iwadate Y, Mine S, Machida T, Sata M, Yamagishi K, Iso H, Sawada N, Tsugane S, Kamitsukasa I, Wada T, Aotsuka A, Sugimoto K, Takizawa H, Kashiwado K, Shin H, Tomiyoshi G, Nakamura R, Shinmen N, Kuroda H, Xu A, Hiwasa T. Wang H, et al. Among authors: matsutani t. BMC Neurol. 2021 Jul 9;21(1):274. doi: 10.1186/s12883-021-02301-w. BMC Neurol. 2021. PMID: 34243715 Free PMC article.

2

High serum level of plasminogen activator inhibitor-1 predicts histological grade of intracerebral gliomas.

Iwadate Y, Hayama M, Adachi A, Matsutani T, Nagai Y, Hiwasa T, Saeki N. Iwadate Y, et al. Among authors: matsutani t. Anticancer Res. 2008 Jan-Feb;28(1B):415-8. Anticancer Res. 2008. PMID: 18383878 Free article.

3

Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.

Matsutani T, Nagai Y, Mine S, Murai H, Saeki N, Iwadate Y. Matsutani T, et al. Acta Neurochir (Wien). 2009 Mar;151(3):263-8; discussion 268. doi: 10.1007/s00701-009-0199-3. Epub 2009 Feb 25. Acta Neurochir (Wien). 2009. PMID: 19240976

4

Activation of NFAT signal by p53-K120R mutant.

Shinmen N, Koshida T, Kumazawa T, Sato K, Shimada H, Matsutani T, Iwadate Y, Takiguchi M, Hiwasa T. Shinmen N, et al. Among authors: matsutani t. FEBS Lett. 2009 Jun 18;583(12):1916-22. doi: 10.1016/j.febslet.2009.04.041. Epub 2009 May 3. FEBS Lett. 2009. PMID: 19416725 Free article.

5

Favorable long-term outcome of low-grade oligodendrogliomas irrespective of 1p/19q status when treated without radiotherapy.

Iwadate Y, Matsutani T, Hasegawa Y, Shinozaki N, Higuchi Y, Saeki N. Iwadate Y, et al. Among authors: matsutani t. J Neurooncol. 2011 May;102(3):443-9. doi: 10.1007/s11060-010-0340-4. Epub 2010 Aug 19. J Neurooncol. 2011. PMID: 20721680

6

Discrimination between low-grade oligodendrogliomas and diffuse astrocytoma with the aid of 11C-methionine positron emission tomography.

Shinozaki N, Uchino Y, Yoshikawa K, Matsutani T, Hasegawa A, Saeki N, Iwadate Y. Shinozaki N, et al. Among authors: matsutani t. J Neurosurg. 2011 Jun;114(6):1640-7. doi: 10.3171/2010.11.JNS10553. Epub 2011 Jan 7. J Neurosurg. 2011. PMID: 21214332

7

Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy.

Iwadate Y, Matsutani T, Shinozaki N, Saeki N. Iwadate Y, et al. Among authors: matsutani t. Anticancer Res. 2011 Dec;31(12):4475-9. Anticancer Res. 2011. PMID: 22199318

8

Autologous antibody to src-homology 3-domain GRB2-like 1 specifically increases in the sera of patients with low-grade gliomas.

Matsutani T, Hiwasa T, Takiguchi M, Oide T, Kunimatsu M, Saeki N, Iwadate Y. Matsutani T, et al. J Exp Clin Cancer Res. 2012 Oct 11;31(1):85. doi: 10.1186/1756-9966-31-85. J Exp Clin Cancer Res. 2012. PMID: 23050879 Free PMC article.

9

Selection of chemotherapy for glioblastoma expressing O(6)-methylguanine-DNA methyltransferase.

Iwadate Y, Matsutani T, Hasegawa Y, Shinozaki N, Oide T, Tanizawa T, Nakatani Y, Saeki N, Fujimoto S. Iwadate Y, et al. Among authors: matsutani t. Exp Ther Med. 2010 Jan;1(1):53-57. doi: 10.3892/etm_00000009. Epub 2010 Jan 1. Exp Ther Med. 2010. PMID: 23136592 Free PMC article.

10

Non-deep-seated primary CNS lymphoma: therapeutic responses and a molecular signature.

Iwadate Y, Suganami A, Ikegami S, Shinozaki N, Matsutani T, Tamura Y, Saeki N, Yamanaka R. Iwadate Y, et al. Among authors: matsutani t. J Neurooncol. 2014 Apr;117(2):261-8. doi: 10.1007/s11060-014-1379-4. Epub 2014 Feb 1. J Neurooncol. 2014. PMID: 24488444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page